| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |